ArticleSystematic reviews2024

Risk of cancer development associated with disease-modifying therapies for multiple sclerosis: study protocol for a systematic review and meta-analysis of randomised and non-randomised studies.

Ferrán Catalá-López et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.